NCT01416311
- Conditions
- Blood Coagulation Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
Not specified
Clinical trial condition
Purpura, Thrombocytopaenic, Idiopathic
Explore clinical trials studying Purpura, Thrombocytopaenic, Idiopathic. Study availability and eligibility vary by location and protocol.
13 public trials
0 recruiting studies
Purpura, Thrombocytopaenic, Idiopathic trial results
NCT00908037
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- GSK Investigational Site Phoenix, Arizona, United States
- GSK Investigational Site Orange, California, United States
- GSK Investigational Site Jacksonville, Florida, United States
- GSK Investigational Site Orlando, Florida, United States
NCT00688272
- Conditions
- Blood Coagulation Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
- Locations
-
- GSK Investigational Site Dundee, United Kingdom
Completed
Relative Bioavailibilty for Pediatric Powder for Suspension (PfOS) Formulation and Food Effect
NCT01072162
- Conditions
- Blood Coagulation Disorders, Hematologic Diseases, Hemic and Lymphatic Diseases, +7 more
- Locations
-
- GSK Investigational Site Buffalo, New York, United States
Completed
Study Of SB-497115 in Healthy Subjects and Subjects With Mild, Moderate or Severe Renal Impairment
NCT00442871
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +17 more
- Locations
-
- GSK Investigational Site Gainesville, Florida, United States
- GSK Investigational Site Saint Paul, Minnesota, United States
NCT00359463
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +10 more
- Locations
-
- GSK Investigational Site Gainesville, Florida, United States
- GSK Investigational Site Orlando, Florida, United States
- GSK Investigational Site Randwick, Sydney, New South Wales, Australia
- GSK Investigational Site Adelaide, South Australia, Australia
NCT00370331
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- GSK Investigational Site Duarte, California, United States
- GSK Investigational Site Los Angeles, California, United States
- GSK Investigational Site San Francisco, California, United States
- GSK Investigational Site Washington D.C., District of Columbia, United States
NCT00351468
- Conditions
- Autoimmune Diseases, Blood Coagulation Disorders, Blood Platelet Disorders, +16 more
- Locations
-
- Novartis Investigative Site Huntsville, Alabama, United States
- Novartis Investigative Site Mobile, Alabama, United States
- Novartis Investigative Site Jonesboro, Arkansas, United States
- Novartis Investigative Site Duarte, California, United States
NCT00643929
- Conditions
- Blood Coagulation Disorders, Cataract, Eye Diseases, +10 more
- Locations
-
- GSK Investigational Site Tucson, Arizona, United States
- GSK Investigational Site Washington D.C., District of Columbia, United States
- GSK Investigational Site Detroit, Michigan, United States
- GSK Investigational Site Durham, North Carolina, United States
Completed
Promacta Pregnancy Registry
NCT01064336
- Conditions
- Blood Coagulation Disorders, Blood Platelet Disorders, Cytopenia, +10 more
- Locations
-
Not specified